P Bourlioux

970 total citations
31 papers, 613 citations indexed

About

P Bourlioux is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, P Bourlioux has authored 31 papers receiving a total of 613 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 8 papers in Epidemiology and 6 papers in Molecular Biology. Recurrent topics in P Bourlioux's work include Clostridium difficile and Clostridium perfringens research (10 papers), Gastrointestinal motility and disorders (5 papers) and Gut microbiota and health (5 papers). P Bourlioux is often cited by papers focused on Clostridium difficile and Clostridium perfringens research (10 papers), Gastrointestinal motility and disorders (5 papers) and Gut microbiota and health (5 papers). P Bourlioux collaborates with scholars based in France, Czechia and Germany. P Bourlioux's co-authors include Véronique Braesco, Berthold Koletzko, Francisco Guarner, Gérard Corthier, Sylvie Pérelle, Michel R. Popoff, Maryse Gibert, Helen Giamarellou, Patrice Courvalin and Marie-Cécile Ploy and has published in prestigious journals such as American Journal of Clinical Nutrition, Applied and Environmental Microbiology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

P Bourlioux

31 papers receiving 569 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P Bourlioux France 8 293 218 122 107 105 31 613
R. P. Jechorek United States 9 159 0.5× 155 0.7× 36 0.3× 99 0.9× 104 1.0× 13 469
M C Muller France 9 250 0.9× 233 1.1× 76 0.6× 53 0.5× 115 1.1× 12 458
Krista Lõivukene Estonia 15 158 0.5× 283 1.3× 44 0.4× 127 1.2× 232 2.2× 30 798
Kentaro Oka Japan 19 327 1.1× 485 2.2× 68 0.6× 82 0.8× 137 1.3× 47 917
R. Mitra United States 18 238 0.8× 183 0.8× 137 1.1× 167 1.6× 307 2.9× 29 1.1k
S. Want United Kingdom 12 242 0.8× 236 1.1× 29 0.2× 71 0.7× 194 1.8× 20 692
H. Boureau France 9 362 1.2× 241 1.1× 36 0.3× 32 0.3× 108 1.0× 18 551
Masoumeh Azimirad Iran 17 376 1.3× 323 1.5× 60 0.5× 43 0.4× 110 1.0× 72 777
Alicja Budak Poland 17 221 0.8× 208 1.0× 31 0.3× 54 0.5× 126 1.2× 42 723
Hongying Fan China 13 145 0.5× 250 1.1× 55 0.5× 77 0.7× 133 1.3× 38 541

Countries citing papers authored by P Bourlioux

Since Specialization
Citations

This map shows the geographic impact of P Bourlioux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P Bourlioux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P Bourlioux more than expected).

Fields of papers citing papers by P Bourlioux

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P Bourlioux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P Bourlioux. The network helps show where P Bourlioux may publish in the future.

Co-authorship network of co-authors of P Bourlioux

This figure shows the co-authorship network connecting the top 25 collaborators of P Bourlioux. A scholar is included among the top collaborators of P Bourlioux based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P Bourlioux. P Bourlioux is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Batista, Rui, Nathalie Kapel, J.C. Chaumeil, et al.. (2015). Le transfert de microbiote fécal lors d’infections récidivantes à Clostridium difficile. Cadre et aspects pharmacotechniques. Annales Pharmaceutiques Françaises. 73(5). 323–331. 5 indexed citations
2.
Bourlioux, P. (2015). Faecal microbiota transplantation: Key points to consider. Annales Pharmaceutiques Françaises. 73(3). 163–168. 8 indexed citations
3.
Bourlioux, P, et al.. (2014). Pourquoi la flore intestinale a-t-elle vocation à devenir médicament ?. Annales Pharmaceutiques Françaises. 72(5). 325–329. 4 indexed citations
4.
Barbut, Frédéric, Anne Collignon, Marie‐José Butel, & P Bourlioux. (2014). Le transfert de flore digestive : une revue de la littérature. Annales Pharmaceutiques Françaises. 73(1). 13–21. 5 indexed citations
5.
Bourlioux, P. (2013). Actualité du microbiote intestinal. Annales Pharmaceutiques Françaises. 72(1). 15–21. 6 indexed citations
6.
Bourlioux, P, Véronique Braesco, & Denis D.G. Mater. (2011). Yoghurts and other fermented milks. 1 indexed citations
7.
Jaffiol, C, et al.. (2011). Réflexions et propositions relatives aux allégations de santé , et aux compléments alimentaires. Bulletin de l Académie Nationale de Médecine. 195(1). 189–202. 1 indexed citations
8.
Bourlioux, P, Véronique Braesco, & Denis D.G. Mater. (2011). Yaourts et autres laits fermentés. Cahiers de Nutrition et de Diététique. 46(6). 305–314. 7 indexed citations
9.
Bourlioux, P, Berthold Koletzko, Francisco Guarner, & Véronique Braesco. (2003). The intestine and its microflora are partners for the protection of the host: report on the Danone Symposium “The Intelligent Intestine,” held in Paris, June 14, 2002. American Journal of Clinical Nutrition. 78(4). 675–683. 254 indexed citations
10.
Eveillard, Matthieu, et al.. (2001). Bacteriological Validation of a New Apparatus for Disinfection of Hospital Waste at the Point of Disposal. Infection Control and Hospital Epidemiology. 22(2). 94–98. 2 indexed citations
11.
Eveillard, Matthieu, et al.. (2000). Association Between the Use of Anticholinergic Agents and Asymptomatic Bacteriuria. European Journal of Clinical Microbiology & Infectious Diseases. 19(2). 149–150. 2 indexed citations
12.
Pérelle, Sylvie, Maryse Gibert, P Bourlioux, Gérard Corthier, & Michel R. Popoff. (1997). Production of a complete binary toxin (actin-specific ADP-ribosyltransferase) by Clostridium difficile CD196. Infection and Immunity. 65(4). 1402–1407. 224 indexed citations
13.
Karjalainen, T., et al.. (1996). Clostridium difficile Adherence to Mucus: Results of an in vivo and ex vivo Assay. Microbial Ecology in Health and Disease. 9(6). 329–334. 2 indexed citations
14.
Fourniat, J & P Bourlioux. (1989). Activity of capryloyl collagenic acid against bacteria involved in acne. International Journal of Cosmetic Science. 11(6). 253–258. 1 indexed citations
15.
Tekaia, Fredj, et al.. (1989). In vivo standardization of cutaneous bactericidal activity of antiseptics by using monoxenic hairless mice. Applied and Environmental Microbiology. 55(8). 1911–1915. 1 indexed citations
16.
Bourlioux, P, et al.. (1986). Interferences bacteriennes au niveau cutane chez la souris «hairless» dixénique. Canadian Journal of Microbiology. 32(9). 751–755. 2 indexed citations
17.
Bourlioux, P, et al.. (1984). [Digestive and cutaneous colonization of Staphylococcus epidermidis in hairless axenic mice].. PubMed. 135A(2). 319–27. 1 indexed citations
18.
Bourlioux, P, et al.. (1984). [Incidence of isolation and antibiotic resistance of E. coli responsible for urinary infections outside hospitals, in specialized hospitals and in general hospitals].. PubMed. 32(5). 389–92. 2 indexed citations
19.
Bourlioux, P, et al.. (1983). [Frequency of isolation and antibiotic sensitivity of strains of coli bacilli from urinary tract infections isolated in private laboratories].. PubMed. 31(6). 536–9. 1 indexed citations
20.
Bourlioux, P, et al.. (1983). [Evaluation of bactericidal activity of antiseptics on the cutaneous flora of holoxenic hairless mouse].. PubMed. 134A(1). 115–24. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R. P. Jechorek Breakdown of academic impact, for papers by M C Muller Breakdown of academic impact, for papers by Krista Lõivukene Breakdown of academic impact, for papers by Kentaro Oka Breakdown of academic impact, for papers by R. Mitra Breakdown of academic impact, for papers by S. Want Breakdown of academic impact, for papers by H. Boureau Breakdown of academic impact, for papers by Masoumeh Azimirad Breakdown of academic impact, for papers by Alicja Budak Breakdown of academic impact, for papers by Hongying Fan
Rankless by CCL
2026